Medium chain acyl-CoA dehydrogenase deficiency ("MCADD") is a rare genetic metabolic disorder. It is a type of fatty acid oxidation disorder. MCADD is estimated to affect one (1) in every seventeen thousand (17,000) people.
Newborn screening in the United States dates back to the early 1960s. Before this time, the focus on infant mortality related primarily to diarrheal diseases, influenza, and other infectious diseases.
Through Minutes Matter – MCADD, I have had the pleasure of becoming acquainted with Heather Ross Wedding. Thanks to Heather’s introduction, I then had the honor of speaking with Dr. Charles Roe, a man whom each of us that has been touched by MCADD owe a great deal of thanks and appreciation. It is quite […]
